查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1916712

益生菌和益生元市场预测至2032年：按产品、来源、剂型、通路、应用、最终用户和地区分類的全球分析

Probiotic & Prebiotic Market Forecasts to 2032 - Global Analysis By Product (Probiotics and Prebiotics), Source, Form, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球益生菌和益生元市场价值将达到 653.4 亿美元，到 2032 年将达到 1,049.2 亿美元，在预测期内的复合年增长率为 7.0%。

益生菌和益生元是互补成分，共同维持健康的肠道菌丛和整体健康。益生菌是活的、有益的微生物，常见于发酵食品和膳食补充剂中，有助于平衡肠道菌丛、改善消化、增强免疫力并促进代谢健康。益生元则是不可消化的膳食纤维和化合物，它们为这些有益微生物提供营养，促进其在肠道内的生长和活性。益生菌和益生元的结合可产生协同效应，改善营养吸收、增强免疫功能、调节肠道菌丛，并有助于长期消化器官系统的平衡和健康。

人们对肠道环境的兴趣日益浓厚

益生菌和益生元市场的发展主要得益于人们对肠道健康与整体健康之间联繫的认识不断提高。消费者越来越意识到消化平衡在免疫、代谢和心理健康方面的重要作用。这种认识，加上临床研究和医疗建议的支持，正在推动对机能性食品、膳食补充剂和强化产品的需求。随着人们生活方式的健康意识增强，预防保健的重要性日益凸显，益生菌和益生元不再是小众产品，而是成为全球市场日常营养的重要组成部分。

生产和仓储成本高

高昂的生产和储存成本仍是阻碍因素市场发展的主要因素。益生菌需要受控的生产环境、先进的发酵过程和严格的温度控制才能维持微生物的活性。此外，低温运输物流和特殊包装也会增加营运成本。这些因素推高了产品价格，并限制了成本敏感地区的市场进入。如何在确保品质的同时控製成本，一直是製造商面临的挑战，这可能会阻碍市场渗透。

创新和产品多元化

创新和产品多元化正在为益生菌和益生元市场创造巨大的机会。製造商正在开发新型菌株、合益素配方以及新的产品形式，例如软糖、饮料和强化食品。个人化营养、微生物组研究和植物来源食品替代品的进步进一步扩大了市场潜力。这些创新使企业能够瞄准不同的消费群体，包括儿童、老年人和运动员。随着科学和消费者偏好的不断发展，差异化产品正成为竞争激烈的全球市场中的关键驱动力。

监管挑战

监管挑战对市场构成重大威胁。各地在健康声明、标籤和菌株核准方面的法规差异，为全球製造商带来了许多复杂问题。严格的合规要求可能会延迟产品上市并增加研发成本。此外，科学检验标准的不一致也可能限制行销的柔软性。随着监管机构加强审查以确保消费者安全，企业必须谨慎应对不断变化的监管环境，才能在这个快速成长的市场中保持信誉并实现长期发展。

新冠疫情的影响：

新冠疫情加速了消费者对免疫力和预防保健的关注，从而对市场产生了积极影响。消费者对支持消化系统健康和免疫力维护的产品，尤其是膳食补充剂和机能性食品的需求激增。然而，供应链中断和原材料短缺暂时影响了生产和分销。儘管面临这些挑战，疫情提高了人们的长期健康意识，从而在疫情后保持了持续的需求，并强化了益生菌和益生元在全球日常健康生活中的重要作用。

预计在预测期内，软糖类产品将占据最大的市场份额。

由于其便利性、偏好口感和易服用性，预计在预测期内，软糖产品将占据最大的市场份额。软糖深受儿童、成人和老年消费者的喜爱，他们正在寻找胶囊和粉末的替代品。软糖诱人的口味和形式有助于提高遵守用药和每日摄取量。此外，製造商在不影响功效的前提下，不断采用先进的配方技术，使益生菌和益生元软糖成为全球市场主导且深受消费者欢迎的产品类型。

预计在预测期内，製药业将呈现最高的复合年增长率。

由于益生菌和益生元的临床疗效不断检验，并在医疗保健领域广泛应用，预计在预测期内，医药领域将呈现最高的成长率。其成长主要得益于益生菌和益生元在胃肠道疾病、免疫调节和抗生素相关疾病等治疗应用中的日益普及。医疗专业人员会开立药用级製剂，因为其剂量标准化且疗效已得到证实。随着研究的深入和监管核准的增加，医药应用预计将快速增长，从而提升该领域在整体市场份额中的比例。

占比最大的地区：

预计亚太地区将在预测期内占据最大的市场份额，这主要得益于该地区人口密度高、中产阶级收入不断增长以及发酵食品在文化上被广泛接受，这些因素将促进发酵食品的普及。健康意识的提高、膳食补充剂行业的扩张以及都市化进程的加速将进一步推动市场需求。此外，中国、日本和印度等国家机能性食品消费量的快速成长，已使亚太地区成为益生菌和益生元的主要区域市场。

复合年增长率最高的地区：

在预测期内，北美地区预计将实现最高的复合年增长率，这主要得益于其先进的医疗保健基础设施和消费者对肠道健康的高度关注。对膳食补充剂、机能饮料和药用级产品的强劲需求正在推动市场快速成长。持续的创新、广泛的临床研究以及零售和线上通路的广泛覆盖，都为市场的进一步扩张提供了支持。该地区对预防性医疗保健和个人化营养的重视，使北美成为益生菌和益生元市场的主要成长引擎。

关于免费客製化服务：

购买此报告的客户可以选择以下免费自订选项之一：

  • 公司概况
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户要求，提供主要国家的市场估算和预测以及复合年增长率（註：可行性需确认）。
  • 竞争标竿分析
    • 根据主要企业的产品系列、地理覆盖范围和策略联盟进行基准分析

目录

第一章执行摘要

第二章 前言

  • 概括
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球益生菌和益生元市场（按产品划分）

  • 益生菌
    • 乳酸菌
    • 双歧桿菌
    • 链球菌
    • 芽孢桿菌
    • 酵母菌
  • 益生元
    • 菊糖
    • 寡果醣（FOS）
    • 半乳寡糖（GOS）
    • 甘露聚醣（MOS）

6. 全球益生菌和益生元市场（依来源划分）

  • 植物来源
  • 动物源性
  • 微生物来源

7. 全球益生菌和益生元市场（按形式划分）

  • 胶囊和片剂
  • 粉末
  • 液体
  • 软糖
  • 小袋

8. 全球益生菌和益生元市场（按分销管道划分）

  • 超级市场和大卖场
  • 药房和药品商店
  • 专卖店
  • 线上零售
  • 直销

9. 全球益生菌和益生元市场（按应用领域划分）

  • 功能性食品和饮料
    • 乳製品
    • 麵包糖果甜点
    • 非乳製品饮料
  • 营养补充品
  • 动物饲料
    • 家禽
    • 猪
    • 反刍动物
    • 水产养殖
  • 婴儿奶粉
  • 製药

10. 全球益生菌和益生元市场（按最终用户划分）

  • 成人
  • 老年人
  • 婴幼儿
  • 畜牧养殖户

第十一章 全球益生菌与益生元市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十三章：企业概况

  • Nestle
  • Danone
  • Yakult Honsha
  • Ingredion Incorporated
  • Chr. Hansen
  • Roquette Freres
  • DuPont de Nemours
  • Lallemand
  • Kerry Group
  • BioGaia
  • Archer Daniels Midland Company（ADM）
  • Probi AB
  • Cargill
  • Lifeway Foods
  • BENEO GmbH
Product Code: SMRC33285

According to Stratistics MRC, the Global Probiotic & Prebiotic Market is accounted for $65.34 billion in 2025 and is expected to reach $104.92 billion by 2032 growing at a CAGR of 7.0% during the forecast period. Probiotics and prebiotics are complementary components that support a healthy gut microbiome and overall well-being. Probiotics are live beneficial microorganisms, commonly found in fermented foods and dietary supplements, that help balance intestinal bacteria, improve digestion, enhance immunity, and support metabolic health. Prebiotics, on the other hand, are non-digestible fibers and compounds that serve as nourishment for these beneficial microbes, stimulating their growth and activity in the gut. When combined, probiotics and prebiotics work synergistically to improve nutrient absorption, strengthen immune function, regulate gut health, and contribute to long-term digestive balance and wellness.

Market Dynamics:

Driver:

Growing Awareness of Gut Health

The probiotic and prebiotic market is strongly driven by growing awareness of gut health and its connection to overall wellness. Consumers increasingly recognize the role of digestive balance in immunity, metabolism, and mental health. This awareness, supported by clinical research and healthcare recommendations, has fueled demand for functional foods, supplements, and fortified products. As lifestyles become more health-conscious and preventive care gains importance, probiotics and prebiotics are no longer niche products but staples in daily nutrition routines across global markets.

Restraint:

High Production & Storage Costs

High production and storage costs remain a significant restraint for the market. Probiotics require controlled manufacturing environments, advanced fermentation processes, and strict temperature regulation to maintain microbial viability. Additionally, cold-chain logistics and specialized packaging increase operational expenses. These factors raise product prices, limiting accessibility in cost-sensitive regions. For manufacturers, maintaining quality while managing costs poses ongoing challenges, which can restrict market penetration.

Opportunity:

Innovation & Product Diversification

Innovation and product diversification present substantial opportunities for the probiotic and prebiotic market. Manufacturers are developing novel strains, synbiotic formulations, and delivery formats such as gummies, beverages, and fortified foods. Advances in personalized nutrition, microbiome research, and plant-based alternatives further expand market potential. These innovations allow companies to target diverse consumer groups, including children, seniors, and athletes. As science and consumer preferences evolve, differentiated products are becoming key growth drivers in competitive global markets.

Threat:

Regulatory Challenges

Regulatory challenges pose a notable threat to the market. Varying regulations across regions regarding health claims, labeling, and strain approval create complexities for global manufacturers. Strict compliance requirements can delay product launches and increase development costs. Additionally, inconsistent scientific validation standards may limit marketing flexibility. As authorities tighten oversight to ensure consumer safety, companies must navigate evolving regulatory landscapes carefully to sustain credibility and long-term growth in this rapidly expanding market.

Covid-19 Impact:

The COVID-19 pandemic positively influenced the market by accelerating consumer focus on immunity and preventive healthcare. Demand surged for products supporting digestive health and immune resilience, particularly supplements and functional foods. However, supply chain disruptions and raw material shortages temporarily affected production and distribution. Despite these challenges, the pandemic reinforced long-term health awareness, leading to sustained post-COVID demand and strengthening the role of probiotics and prebiotics in daily wellness routines worldwide.

The gummies segment is expected to be the largest during the forecast period

The gummies segment is expected to account for the largest market share during the forecast period, due to their convenience, palatable taste, and ease of consumption. Gummies appeal strongly to children, adults, and elderly consumers who prefer alternatives to capsules or powders. Their attractive flavors and formats improve compliance and daily intake consistency. Additionally, manufacturers are incorporating advanced formulations without compromising efficacy, making probiotic and prebiotic gummies a dominant and consumer-friendly product category in the global market.

The pharmaceuticals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate, due to rising clinical validation and medical adoption of probiotics and prebiotics. Increasing use in therapeutic applications such as gastrointestinal disorders, immune modulation, and antibiotic-associated conditions supports growth. Healthcare professionals are prescribing pharmaceutical-grade formulations due to standardized dosages and proven efficacy. As research expands and regulatory approvals increase, pharmaceutical applications are expected to grow rapidly, strengthening this segment's contribution to overall market.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to high population density, growing middle-class income, and strong cultural acceptance of fermented foods support widespread adoption. Rising health awareness, expanding nutraceutical industries, and increasing urbanization further drives demand. Additionally, countries such as China, Japan, and India are witnessing rapid growth in functional food consumption, positioning Asia Pacific as a dominant regional market for probiotics and prebiotics.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced healthcare infrastructure and high consumer awareness of gut health. Strong demand for dietary supplements, functional beverages, and pharmaceutical-grade products fuels rapid growth. Continuous innovation, extensive clinical research, and widespread availability across retail and online channels further support expansion. The region's focus on preventive healthcare and personalized nutrition makes North America a key growth engine for the probiotic and prebiotic market.

Key players in the market

Some of the key players in Probiotic & Prebiotic Market include Nestle, Danone, Yakult Honsha, Ingredion Incorporated, Chr. Hansen, Roquette Freres, DuPont de Nemours, Lallemand, Kerry Group, BioGaia, Archer Daniels Midland Company (ADM), Probi AB, Cargill, Lifeway Foods, and BENEO GmbH.

Key Developments:

In October 2025, Nestle Saudi Arabia and King Abdullah University of Science and Technology (KAUST) signed a strategic MoU this partnership blends KAUST's world-class research excellence with Nestle's global food technology know-how to promote sustainability, food safety, and healthier lifestyles, supporting Saudi Vision 2030 goals while enhancing public health, food security, and local knowledge development.

In July 2025, Nestle and IBM Research have woven old-world stewardship with cutting-edge AI, creating a generative tool that can dream up new high-barrier packaging materials-shielding products from moisture, oxygen and heat while pushing sustainability forward faster than years of lab work.

Products Covered:

  • Probiotics
  • Prebiotics

Sources Covered:

  • Plant-Based
  • Animal-Based
  • Microbial

Forms Covered:

  • Capsules & Tablets
  • Powders
  • Liquids
  • Gummies
  • Sachets

Distribution Channels Covered:

  • Supermarkets & Hypermarkets
  • Pharmacies & Drug Stores
  • Specialty Stores
  • Online Retail
  • Direct Sales

Applications Covered:

  • Functional Food & Beverages
  • Dietary Supplements
  • Animal Feed
  • Infant Formula
  • Pharmaceuticals

End Users Covered:

  • Adults
  • Geriatric Population
  • Infants & Children
  • Livestock Producers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Probiotic & Prebiotic Market, By Product

  • 5.1 Introduction
  • 5.2 Probiotics
    • 5.2.1 Lactobacillus
    • 5.2.2 Bifidobacterium
    • 5.2.3 Streptococcus
    • 5.2.4 Bacillus
    • 5.2.5 Yeast
  • 5.3 Prebiotics
    • 5.3.1 Inulin
    • 5.3.2 Fructooligosaccharides (FOS)
    • 5.3.3 Galactooligosaccharides (GOS)
    • 5.3.4 Mannan-oligosaccharides (MOS)

6 Global Probiotic & Prebiotic Market, By Source

  • 6.1 Introduction
  • 6.2 Plant-Based
  • 6.3 Animal-Based
  • 6.4 Microbial

7 Global Probiotic & Prebiotic Market, By Form

  • 7.1 Introduction
  • 7.2 Capsules & Tablets
  • 7.3 Powders
  • 7.4 Liquids
  • 7.5 Gummies
  • 7.6 Sachets

8 Global Probiotic & Prebiotic Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Supermarkets & Hypermarkets
  • 8.3 Pharmacies & Drug Stores
  • 8.4 Specialty Stores
  • 8.5 Online Retail
  • 8.6 Direct Sales

9 Global Probiotic & Prebiotic Market, By Application

  • 9.1 Introduction
  • 9.2 Functional Food & Beverages
    • 9.2.1 Dairy Products
    • 9.2.2 Bakery & Confectionery
    • 9.2.3 Non-Dairy Beverages
  • 9.3 Dietary Supplements
  • 9.4 Animal Feed
    • 9.4.1 Poultry
    • 9.4.2 Swine
    • 9.4.3 Ruminants
    • 9.4.4 Aquaculture
  • 9.5 Infant Formula
  • 9.6 Pharmaceuticals

10 Global Probiotic & Prebiotic Market, By End User

  • 10.1 Introduction
  • 10.2 Adults
  • 10.3 Geriatric Population
  • 10.4 Infants & Children
  • 10.5 Livestock Producers

11 Global Probiotic & Prebiotic Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Nestle
  • 13.2 Danone
  • 13.3 Yakult Honsha
  • 13.4 Ingredion Incorporated
  • 13.5 Chr. Hansen
  • 13.6 Roquette Freres
  • 13.7 DuPont de Nemours
  • 13.8 Lallemand
  • 13.9 Kerry Group
  • 13.10 BioGaia
  • 13.11 Archer Daniels Midland Company (ADM)
  • 13.12 Probi AB
  • 13.13 Cargill
  • 13.14 Lifeway Foods
  • 13.15 BENEO GmbH

List of Tables

  • Table 1 Global Probiotic & Prebiotic Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Probiotic & Prebiotic Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Probiotic & Prebiotic Market Outlook, By Probiotics (2024-2032) ($MN)
  • Table 4 Global Probiotic & Prebiotic Market Outlook, By Lactobacillus (2024-2032) ($MN)
  • Table 5 Global Probiotic & Prebiotic Market Outlook, By Bifidobacterium (2024-2032) ($MN)
  • Table 6 Global Probiotic & Prebiotic Market Outlook, By Streptococcus (2024-2032) ($MN)
  • Table 7 Global Probiotic & Prebiotic Market Outlook, By Bacillus (2024-2032) ($MN)
  • Table 8 Global Probiotic & Prebiotic Market Outlook, By Yeast (2024-2032) ($MN)
  • Table 9 Global Probiotic & Prebiotic Market Outlook, By Prebiotics (2024-2032) ($MN)
  • Table 10 Global Probiotic & Prebiotic Market Outlook, By Inulin (2024-2032) ($MN)
  • Table 11 Global Probiotic & Prebiotic Market Outlook, By Fructooligosaccharides (FOS) (2024-2032) ($MN)
  • Table 12 Global Probiotic & Prebiotic Market Outlook, By Galactooligosaccharides (GOS) (2024-2032) ($MN)
  • Table 13 Global Probiotic & Prebiotic Market Outlook, By Mannan-oligosaccharides (MOS) (2024-2032) ($MN)
  • Table 14 Global Probiotic & Prebiotic Market Outlook, By Source (2024-2032) ($MN)
  • Table 15 Global Probiotic & Prebiotic Market Outlook, By Plant-Based (2024-2032) ($MN)
  • Table 16 Global Probiotic & Prebiotic Market Outlook, By Animal-Based (2024-2032) ($MN)
  • Table 17 Global Probiotic & Prebiotic Market Outlook, By Microbial (2024-2032) ($MN)
  • Table 18 Global Probiotic & Prebiotic Market Outlook, By Form (2024-2032) ($MN)
  • Table 19 Global Probiotic & Prebiotic Market Outlook, By Capsules & Tablets (2024-2032) ($MN)
  • Table 20 Global Probiotic & Prebiotic Market Outlook, By Powders (2024-2032) ($MN)
  • Table 21 Global Probiotic & Prebiotic Market Outlook, By Liquids (2024-2032) ($MN)
  • Table 22 Global Probiotic & Prebiotic Market Outlook, By Gummies (2024-2032) ($MN)
  • Table 23 Global Probiotic & Prebiotic Market Outlook, By Sachets (2024-2032) ($MN)
  • Table 24 Global Probiotic & Prebiotic Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 25 Global Probiotic & Prebiotic Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 26 Global Probiotic & Prebiotic Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 27 Global Probiotic & Prebiotic Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 28 Global Probiotic & Prebiotic Market Outlook, By Online Retail (2024-2032) ($MN)
  • Table 29 Global Probiotic & Prebiotic Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 30 Global Probiotic & Prebiotic Market Outlook, By Application (2024-2032) ($MN)
  • Table 31 Global Probiotic & Prebiotic Market Outlook, By Functional Food & Beverages (2024-2032) ($MN)
  • Table 32 Global Probiotic & Prebiotic Market Outlook, By Dairy Products (2024-2032) ($MN)
  • Table 33 Global Probiotic & Prebiotic Market Outlook, By Bakery & Confectionery (2024-2032) ($MN)
  • Table 34 Global Probiotic & Prebiotic Market Outlook, By Non-Dairy Beverages (2024-2032) ($MN)
  • Table 35 Global Probiotic & Prebiotic Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 36 Global Probiotic & Prebiotic Market Outlook, By Animal Feed (2024-2032) ($MN)
  • Table 37 Global Probiotic & Prebiotic Market Outlook, By Poultry (2024-2032) ($MN)
  • Table 38 Global Probiotic & Prebiotic Market Outlook, By Swine (2024-2032) ($MN)
  • Table 39 Global Probiotic & Prebiotic Market Outlook, By Ruminants (2024-2032) ($MN)
  • Table 40 Global Probiotic & Prebiotic Market Outlook, By Aquaculture (2024-2032) ($MN)
  • Table 41 Global Probiotic & Prebiotic Market Outlook, By Infant Formula (2024-2032) ($MN)
  • Table 42 Global Probiotic & Prebiotic Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 43 Global Probiotic & Prebiotic Market Outlook, By End User (2024-2032) ($MN)
  • Table 44 Global Probiotic & Prebiotic Market Outlook, By Adults (2024-2032) ($MN)
  • Table 45 Global Probiotic & Prebiotic Market Outlook, By Geriatric Population (2024-2032) ($MN)
  • Table 46 Global Probiotic & Prebiotic Market Outlook, By Infants & Children (2024-2032) ($MN)
  • Table 47 Global Probiotic & Prebiotic Market Outlook, By Livestock Producers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.